PBS Website Update - 1 January 2011

1 January 2011

The Schedule of Pharmaceutical Benefits was updated on 1 January 2011 and the Summary of Changes can be found on the New amended and deleted items page. Detailed information regarding additions and alterations of restrictions is now available in the fact sheet, New Listings and Changes 1 January 2011.

The following updates have also been made to the PBS Website:

• 2011 PBS copayment and Safety Net amounts
• Expanded and Accelerated Price Disclosure (EAPD)

Please note, the following generic drug name changes advised in the 1 January 2011 Summary of Changes, are not shown in the PBS data or Schedule. The generic drug names will be updated in the 1 February 2011 PBS Data and Schedule.

Section 100 — Highly Specialised Drugs Program
From:
5604Y Abacavir sulfate with Lamivudine and Zidovudine, Tablet 300 mg (base)- 150 mg-300 mg, (Trizivir) (Public)
To:
5604Y Abacavir with Lamivudine and Zidovudine, Tablet containing abacavir 300 mg (as sulfate) with lamivudine 150 mg and zidovudine 300 mg, (Trizivir) (Public)

From:
6327B Abacavir sulfate with Lamivudine and Zidovudine, Tablet 300 mg (base)- 150 mg-300 mg, (Trizivir) (Private)
To:
6327B Abacavir with Lamivudine and Zidovudine, Tablet containing abacavir 300 mg (as sulfate) with lamivudine 150 mg and zidovudine 300 mg, (Trizivir) (Private)